Navigation Links
Neurology Group Lists Procedures That May Be Unneeded
Date:3/8/2013

FRIDAY, March 8 (HealthDay News) -- Five tests, procedures and treatments that neurologists and their patients should question are outlined in a list released by the American Academy of Neurology (AAN) as part of the Choosing Wisely campaign.

"With one in six people affected by a brain disease, such as headache, multiple sclerosis and stroke, our goal is to have patients discuss our Choosing Wisely recommendations regarding medical procedures, therapies, and tests with their neurologists," AAN president Dr. Bruce Sigsbee said in an academy news release.

The American Board of Internal Medicine Foundation-led Choosing Wisely campaign involves about 35 medical specialty groups and is intended to encourage patients and doctors to discuss appropriate care while avoiding unnecessary tests and treatments. The AAN is one of 17 medical societies that recently released advice lists.

Here are the AAN's five neurology-related recommendations:

  • Do not perform electroencephalography (EEG) for headaches. Recurrent headache, which is the most common pain problem, affects up to 20 percent of people. EEG increases costs but has no advantage over clinical evaluation in diagnosing headache and it does not improve outcomes.
  • Do not perform imaging of the carotid arteries in the neck for simple fainting in the absence of other neurologic symptoms. Fainting affects up to 40 percent of people during their lifetime. Carotid artery disease does not cause fainting; rather, it causes focused neurologic problems such as weakness on one side of the body. Therefore, carotid imaging will not identify the cause of the fainting, but it does increase costs.
  • When treating migraine, opioid or butalbital drugs should only be used as a last resort. More effective, migraine-specific treatments are available, and frequent use of these drugs can worsen headaches. Opioid (narcotic) use should be reserved for patients with medical conditions that prevent the use of migraine-specific treatments or for patients for whom these treatments don't work.
  • Do not prescribe interferon-beta or glatiramer acetate to patients with disability from progressive, non-relapsing forms of multiple sclerosis. These medications, often prescribed for MS, do not prevent the development of permanent disability in progressive forms of the disease. However, they do have frequent side effects that may negatively affect quality of life, and increase costs as well.
  • Do not recommend carotid endarterectomy for people who have narrowing of the carotid arteries in the neck but have no symptoms, unless the patient's risk of complication is less than 3 percent. Carotid endarterectomy is a type of surgery meant to reduce the risk of stroke.

The recommendations were published online recently in the journal Neurology.

More information

Here's where you can learn more about the Choosing Wisely campaign.

-- Robert Preidt

SOURCE: American Academy of Neurology, news release, Feb. 21, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Wolters Kluwer Health and the American Academy of Neurology renew partnership
2. Loyola Med student wins prize for excellence in neurology
3. Thomas Eye Group Continues Growth in Metro Atlanta Area With Two Clinic Expansions
4. Lupus Support Group Meeting in Fort Wayne on March 28th
5. Lupus Support Group in Traverse City on March 20th
6. Artisan Business Group brings EB-5 Boot Camp to New York City April 10, 2013
7. Ob-Gyn Group Lists Procedures That May Not Be Needed
8. USHEALTH Advisors Teams with Kristen Zebert to Bring USHEALTH Group Products to Oklahoma
9. Stroud launches Watershed Restoration Group to ensure water quality
10. Pediatrics Group Issues New Ear Infection Guidelines
11. Cunningham Financial Group Encourages Residents of Louisiana to Celebrate American Heart Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... CTNext , Connecticut’s ... Awards (EIA), held this past Thursday night at The Space in Hamden. ... their innovative project ideas to a panel of judges for an opportunity to ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... rallying cry to Americans to watch for the discomforts and hidden dangers of ... to senior citizens, everyone is at risk for developing fungal infections on the ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy Management ... delivered. Based on industry research and market feedback, the latest version of ...
(Date:9/19/2017)... Philadelphia, PA (PRWEB) , ... September 19, 2017 ... ... high-quality orthopedic dog beds, has been officially recognized for its September 2016 donation ... , The company recently received three awards and honors for its contribution ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), the company commercializing ... Pharma AG to distribute NuvoAir,s spirometry technology to physicians worldwide. ... platform and Novartis, commitment to address the unmet medical needs ... ... "We are ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
Breaking Medicine Technology: